Pfizer plans job cuts in Switzerland to reduce expenses

Pfizer is acceptable to chopped jobs successful Switzerland arsenic portion of a multi-year effort to little expenses, arsenic reported by Bloomberg.

According to accusation not yet made public, the institution aims to chopped unit from astir 300 to 70.

The simplification follows a broader downgrading of the cause manufacturer’s Swiss operations.

In aboriginal December 2025, Pfizer’s Swiss state manager Sabine Bruckner was replaced by Rea Lal, who present heads the section concern but with a “diminished mandate.”

Bruckner has moved to a antithetic role.

Pfizer is pursuing a cost-reduction program of much than $7bn by 2027, arsenic it seeks to reconstruct maturation successful the years pursuing the pandemic.

A spokesperson described successful an email connection a “streamlining and realigning” of resources to minimise complexity.

Pfizer did not remark connected circumstantial numbers.

The occupation cuts travel arsenic the cpmpany steps up enactment successful the obesity attraction field, confirming a determination into the assemblage via a licensing statement worthy up to $2bn with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical.

YaoPharma volition behaviour an ongoing Phase I proceedings of YP05002 and supply Pfizer with an exclusive licence to further develop, manufacture and commercialise the therapy globally.

Pfizer was precocious progressive successful a bidding warfare with Novo Nordisk to get New York-based obesity biotech Metsera.

Following information of rival bids from the pharma giants, Metsera has accepted Pfizer’s $10bn proposal.

The planned workforce simplification successful Switzerland adds to a bid of akin moves by different pharmaceutical groups successful the country, wherever pharmaceuticals are the largest export sector.

In November 2025, Novartis stated that it would destruct up to 550 jobs successful Switzerland.

"Pfizer plans occupation cuts successful Switzerland to trim expenses" was primitively created and published by Pharmaceutical Technology, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.